...
search icon
rdhl-img

Redhill Biopharma Ltd Share Price

RDHL
NAQ
$1.07
+$0.04
(3.88%)
1D
Industry: Pharmaceuticals Sector: Health Care

Redhill Biopharma Ltd Analyst Forecast

Redhill Biopharma Ltd Share Price Chart

Redhill Biopharma Ltd Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.27M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
37.22K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
4.88
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.91 L
$5.86 H
$1.07

About Redhill Biopharma Ltd, Common Stock

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, prostate cancer, nuclear radiation protection; and host directed anti-viral; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn's disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 that is in Phase 3 clinical trial for the treatment of pulmonary Mycobacterium avium complex disease in adults. The company was incorporated in 2009 and is headquartered in Tel Aviv, Israel. more

Industry: PharmaceuticalsSector: Health Care

Redhill Biopharma Ltd Stock Returns

Time FrameRDHLSectorS&P500
1-Week Return-12.3%0.06%-2.06%
1-Month Return-21.9%-2.06%-2.06%
3-Month Return-7.76%6.1%1.11%
6-Month Return-13.01%18.64%7.13%
1-Year Return-81.71%5.25%11.74%
3-Year Return-99.59%17.35%65.43%
5-Year Return-99.99%33.7%73.53%
10-Year Return-99.99%143.77%266.66%

Redhill Biopharma Ltd Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue64.36M85.76M61.80M6.53M8.04M[{"date":"2020-12-31","value":75.05,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":72.06,"profit":true},{"date":"2023-12-31","value":7.61,"profit":true},{"date":"2024-12-31","value":9.38,"profit":true}]
Cost of Revenue36.89M49.41M33.34M3.46M3.19M[{"date":"2020-12-31","value":74.67,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":67.48,"profit":true},{"date":"2023-12-31","value":7,"profit":true},{"date":"2024-12-31","value":6.46,"profit":true}]
Gross Profit27.47M36.35M28.46M3.07M4.85M[{"date":"2020-12-31","value":75.56,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":78.3,"profit":true},{"date":"2023-12-31","value":8.45,"profit":true},{"date":"2024-12-31","value":13.34,"profit":true}]
Gross Margin42.68%42.39%46.06%47.03%60.31%[{"date":"2020-12-31","value":70.76,"profit":true},{"date":"2021-12-31","value":70.28,"profit":true},{"date":"2022-12-31","value":76.36,"profit":true},{"date":"2023-12-31","value":77.97,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses91.15M117.49M71.31M(9.56M)19.46M[{"date":"2020-12-31","value":77.58,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":60.69,"profit":true},{"date":"2023-12-31","value":-8.14,"profit":false},{"date":"2024-12-31","value":16.57,"profit":true}]
Operating Income(63.68M)(81.14M)(42.84M)12.63M(14.61M)[{"date":"2020-12-31","value":-504.15,"profit":false},{"date":"2021-12-31","value":-642.3,"profit":false},{"date":"2022-12-31","value":-339.17,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-115.68,"profit":false}]
Total Non-Operating Income/Expense(25.06M)(33.19M)(70.07M)9.13M4.49M[{"date":"2020-12-31","value":-274.63,"profit":false},{"date":"2021-12-31","value":-363.69,"profit":false},{"date":"2022-12-31","value":-767.85,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":49.23,"profit":true}]
Pre-Tax Income(76.17M)(97.74M)(71.67M)23.92M(8.27M)[{"date":"2020-12-31","value":-318.5,"profit":false},{"date":"2021-12-31","value":-408.7,"profit":false},{"date":"2022-12-31","value":-299.67,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-34.57,"profit":false}]
Income Taxes12.84M16.57M(12.42M)(2.00)-[{"date":"2020-12-31","value":77.53,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-74.99,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(89.02M)(114.31M)(59.24M)23.92M-[{"date":"2020-12-31","value":-372.21,"profit":false},{"date":"2021-12-31","value":-477.97,"profit":false},{"date":"2022-12-31","value":-247.72,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(76.17M)(97.74M)(71.67M)23.92M(8.27M)[{"date":"2020-12-31","value":-318.5,"profit":false},{"date":"2021-12-31","value":-408.7,"profit":false},{"date":"2022-12-31","value":-299.67,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-34.57,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(76.17M)(97.74M)(71.67M)23.92M(8.27M)[{"date":"2020-12-31","value":-318.5,"profit":false},{"date":"2021-12-31","value":-408.7,"profit":false},{"date":"2022-12-31","value":-299.67,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-34.57,"profit":false}]
EPS (Diluted)(2.10)(2.10)(0.90)(1.54)(204.22)[{"date":"2020-12-31","value":-210,"profit":false},{"date":"2021-12-31","value":-210,"profit":false},{"date":"2022-12-31","value":-90,"profit":false},{"date":"2023-12-31","value":-154.11,"profit":false},{"date":"2024-12-31","value":-20422,"profit":false}]

Redhill Biopharma Ltd Ratios

Redhill Biopharma Ltd Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

RDHL
Cash Ratio 0.13
Current Ratio 0.56
Quick Ratio 0.42

Redhill Biopharma Ltd Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RDHL
ROA (LTM) -25.32%
ROE (LTM) -1708.61%

Redhill Biopharma Ltd Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RDHL
Debt Ratio Lower is generally better. Negative is bad. 1.24
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.24

Redhill Biopharma Ltd Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RDHL
Trailing PE NM
Forward PE 1428.57
P/S (TTM) 0.55
P/B 203.21
Price/FCF NM
EV/R 0.30
EV/Ebitda 0.30
PEG NM

FAQs

What is Redhill Biopharma Ltd share price today?

Redhill Biopharma Ltd (RDHL) share price today is $1.07

Can Indians buy Redhill Biopharma Ltd shares?

Yes, Indians can buy shares of Redhill Biopharma Ltd (RDHL) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RDHL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Redhill Biopharma Ltd be purchased?

Yes, you can purchase fractional shares of Redhill Biopharma Ltd (RDHL) via the Vested app. You can start investing in Redhill Biopharma Ltd (RDHL) with a minimum investment of $1.

How to invest in Redhill Biopharma Ltd shares from India?

You can invest in shares of Redhill Biopharma Ltd (RDHL) via Vested in three simple steps:

  • Click on Sign Up or Invest in RDHL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Redhill Biopharma Ltd shares
What is Redhill Biopharma Ltd 52-week high and low stock price?

The 52-week high price of Redhill Biopharma Ltd (RDHL) is $5.86. The 52-week low price of Redhill Biopharma Ltd (RDHL) is $0.91.

What is Redhill Biopharma Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Redhill Biopharma Ltd (RDHL) is

What is Redhill Biopharma Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Redhill Biopharma Ltd (RDHL) is 203.21

What is Redhill Biopharma Ltd dividend yield?

The dividend yield of Redhill Biopharma Ltd (RDHL) is 0.00%

What is the Market Cap of Redhill Biopharma Ltd?

The market capitalization of Redhill Biopharma Ltd (RDHL) is $5.27M

What is Redhill Biopharma Ltd's stock symbol?

The stock symbol (or ticker) of Redhill Biopharma Ltd is RDHL

How Can Investors Use Redhill Biopharma Ltd Share Price Data for Long-Term Investment Decisions?

Consider the share price of Redhill Biopharma Ltd as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Redhill Biopharma Ltd has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Redhill Biopharma Ltd shares for Indian investors?

When investing in Redhill Biopharma Ltd shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Redhill Biopharma Ltd stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Redhill Biopharma Ltd share price with other stocks in the same sector?

Rather than merely checking the share price of Redhill Biopharma Ltd and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Redhill Biopharma Ltd stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top